Conference Reports for NaTaP

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria  april 22-26 Back

Pharmacokinetics of Miravirsen, a miR-122 Inhibitor, Predict the Prolonged Viral Load Reduction in Treatment Naive Genotype 1 HCV-Infected Patients       Reported by Jules Levin EASL 2015 April 22-26 Vienna Austria   Pdf poster attached